D
Arcturus Therapeutics Holdings Inc. ARCT
$18.51 $1.035.89% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 16.39% 36.44% -172.30% -163.07% -189.63%
Total Depreciation and Amortization -4.17% 4.81% 19.85% 31.45% 51.34%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -16.99% -4.21% 2,885.95% 7,005.39% 1,694.28%
Change in Net Operating Assets -3.69% -174.75% -381.93% -195.47% -179.40%
Cash from Operations 5.52% -831.30% -230.11% -142.08% -151.76%
Capital Expenditure 91.05% 77.76% 77.66% 73.89% 65.56%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 91.05% 77.76% 77.66% 73.89% 65.56%
Total Debt Issued -25.00% -25.00% -- -100.00% --
Total Debt Repaid 25.00% -- -- 34.13% 38.20%
Issuance of Common Stock -83.33% -37.33% 65.33% 145.26% 373.45%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -83.33% 237.15% 122.49% -74.54% 125.30%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -0.75% -569.13% -21.94% -158.00% -166.70%